A detailed history of Farrow Financial Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Farrow Financial Inc. holds 2,446 shares of LLY stock, worth $1.88 Million. This represents 1.37% of its overall portfolio holdings.

Number of Shares
2,446
Previous 2,469 0.93%
Holding current value
$1.88 Million
Previous $2.24 Billion 3.06%
% of portfolio
1.37%
Previous 1.52%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$772.14 - $960.02 $17,759 - $22,080
-23 Reduced 0.93%
2,446 $2.17 Billion
Q2 2024

Jul 15, 2024

BUY
$724.87 - $909.04 $12,322 - $15,453
17 Added 0.69%
2,469 $2.24 Billion
Q1 2024

May 02, 2024

BUY
$592.2 - $792.28 $17,766 - $23,768
30 Added 1.24%
2,452 $1.91 Billion
Q4 2023

Feb 08, 2024

BUY
$525.19 - $619.13 $1.27 Million - $1.5 Million
2,422 New
2,422 $1.41 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Farrow Financial Inc. Portfolio

Follow Farrow Financial Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farrow Financial Inc., based on Form 13F filings with the SEC.

News

Stay updated on Farrow Financial Inc. with notifications on news.